Tumor suppressor role of microRNA-1296 in triple-negative breast cancer

Oncotarget
Binh PhanAltaf A Dar

Abstract

Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a poor prognosis, which lacks effective targeted therapies. There is an urgent need to better understand the underlying molecular mechanisms of TNBC aggressiveness and identify novel, efficient targets for therapeutic intervention. miRNA qRT-PCR was used to determine the expression of miR-1296 in cell lines. The miR-1296 overexpression effects in TNBC cell lines were investigated using assays of colony formation, cell cycle and apoptosis. Immunoblotting was performed to determine the expression of the miR-1296 target protein, and luciferase assays were performed to confirm the target of miR-1296 action. miR-1296 expression was significantly suppressed in TNBC cell lines and tissues samples. Overexpression of miR-1296 significantly suppressed cell proliferation of two TNBC cell lines when compared to control miRNA-expressing cells. A significant decrease in the S-phase of the cell cycle was observed following miR-1296 overexpression, accompanied by induction of apoptosis in TNBC cells. Cyclin D1 (CCND1) was identified as a target of miR-1296 action. miR-1296 overexpression significantly suppressed the luciferase activity of reporter plasmid conta...Continue Reading

References

Oct 6, 1995·The Journal of Biological Chemistry·C AlbaneseR G Pestell
Apr 3, 2004·Trends in Molecular Medicine·Mark E Ewen, Justin Lamb
Aug 28, 2004·Endocrinology·Maofu FuRichard G Pestell
Feb 26, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·R JayasuryaS Kannan
Jun 18, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew Arnold, Alexandros Papanikolaou
Mar 16, 2007·Cancer Science·Etsu TashiroMasaya Imoto
Jun 24, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B SirohiI E Smith
Sep 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Amaia LujambioManel Esteller
Oct 28, 2008·Seminars in Reproductive Medicine·Brian D AdamsBruce A White
Feb 28, 2009·Clinical Chemistry·Claudine L Bartels, Gregory J Tsongalis
May 6, 2009·Journal of Cellular Physiology·Jong Kyong Kim, J Alan Diehl
Dec 24, 2009·Nature Reviews. Cancer·Thomas SantariusColin S Cooper
Jan 16, 2010·The American Journal of Pathology·Zuoren YuRichard G Pestell
Nov 12, 2010·The New England Journal of Medicine·William D FoulkesJorge S Reis-Filho
Mar 23, 2011·Nature Genetics·Susanna ObadSakari Kauppinen
Jul 12, 2011·Physiological Reviews·Danish Sayed, Maha Abdellatif
Apr 21, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K GelmonS Verma
Jun 27, 2012·Expert Opinion on Biological Therapy·Liqin Du, Alexander Pertsemlidis
Oct 4, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C CriscitielloC Sotiriou
Feb 23, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hailing LiuXi-ru Li
Jun 21, 2013·Proceedings of the National Academy of Sciences of the United States of America·Shuet Theng LeeQiang Yu
Oct 2, 2013·Annual Review of Pathology·Gianpiero Di LevaCarlo M Croce
Nov 6, 2014·Experimental and Therapeutic Medicine·Peifen FuYu Liu
Sep 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K GelmonS Verma

❮ Previous
Next ❯

Citations

Sep 5, 2019·Bioscience, Biotechnology, and Biochemistry·Jie ZhangHang He
Sep 8, 2020·Journal of Zhejiang University. Science. B·Juan XuXian-Feng Ding
Aug 15, 2019·Molecular Biology Reports·Samuel C LeeThomas P Quinn
Feb 9, 2021·Technology in Cancer Research & Treatment·Gaolian ZhangWeibin Liang
Dec 18, 2020·Frontiers in Oncology·Simona Ruxandra VolovatIolanda Augustin
Jun 18, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Lamyaa AlbakrFutwan Al-Mohanna
Sep 11, 2021·Current Cancer Drug Targets·Acharya BalkrishnaVedpriya Arya

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
transfections
PCR
electrophoresis
Assay

Software Mentioned

Graphpad Prism
7500 Fast system

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis